Pfizer Looks To Make Its Big Pharma Engine More Agile By Cutting 10,000

Company's reorganization will include R&D rationalization, manufacturing consolidation and European field force cuts.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet